Navigation Links
Grant & Eisenhofer Represents Key Whistleblower in Justice Dept.'s $1.04 Billion Civil Settlement with GlaxoSmithKline

BOSTON and WASHINGTON, July 2, 2012 /PRNewswire/ -- Leading whistleblower law firm Grant & Eisenhofer has represented one of several key whistleblowers behind a $1.04 billion settlement announced today between drug maker GlaxoSmithKline and the U.S. Department of Justice stemming from alleged marketing abuses of various GSK medications. Grant & Eisenhofer's client, Lois Graydon, is a nursing professional and former GSK Therapeutic Sales Manager. 

The U.S. Attorney's office in Boston led the investigation into promotional tactics behind a total of nine GSK drugs. An accompanying criminal component of the case is expected to substantially increase the sum of the recovery.

Grant & Eisenhofer partner Reuben Guttman and senior counsel Traci Buschner are counsel to Lois Graydon, a registered nurse.  She is one of the "relators" who alleged that GSK made false and misleading statements about Advair's safety and efficacy, thus enabling false or fraudulent claims to Medicare, Medicaid, and other reimbursement programs.

Advair's share of the recovery – more than $700 million – amounts to over half of the total civil settlement of $1.04 billion.

"The False Claims Act plays an important role in health industry compliance enforcement; health care is an issue that touches everyone and oversight, diligence and transparency are critical," said Mr. Guttman, one of the country's leading whistleblower attorneys.

"It is important that the medical community pays attention to this settlement and others and asks critical questions about the scientific support for the use of prescription drugs," he added.

"In this election year, the safety of pharmaceuticals and their cost to the health care system should be front and center," Mr. Guttman said.

He added, "Whistleblowers play an important role in compliance enforcement of our laws. We were proud to have represented one of the whistleblowers on this important case under the False Claims Act."

The GSK settlement is the latest in a series of high-profile outcomes for Mr. Guttman on behalf of individual whistleblowers. The firm represented plaintiff Lynn Szymoniak, profiled on 60 Minutes as a homeowner facing foreclosure and later whistleblower on "robo-signing" fraud by large mortgage providers including Citigroup, Bank of America, JP Morgan Chase, and Wells Fargo. The group of banks concluded a settlement with the Justice Department and state Attorneys General this past March for $25 billion.

Grant & Eisenhofer also represented an Abbott Laboratories sales manager who alleged the company illegally marketed its powerful anti-seizure medication Depakote, while making kickbacks to physicians to prescribe it. Among other allegations, Abbott was accused of promoting Depakote for use in nursing homes to sedate patients with dementia and Alzheimer's, as well as for hard-to-control children. The company was also charged with making illegal payments to medical practitioners to prescribe it. This past May, Abbott agreed to pay $1.6 billion to settle the claims, one of the largest payments ever for off-label marketing of a single drug. Mr. Guttman and Ms. Buschner's client was lead whistleblower when the Justice Department intervened on her behalf.

Mr. Guttman and Ms. Buschner currently represent several relators in an ongoing government case against defense contractor Lockheed Martin regarding alleged environmental noncompliance and mishandling of hazardous waste at one of its plants. The Natural Resources Defense Council has joined the government's case. Additionally, Mr. Guttman and Ms. Buschner are counsel to one of the relators in a case against Wyeth (now owned by Pfizer) over alleged off-label marketing of Rapamune, its immunosuppressant post-organ transplant drug.

Note: Grant & Eisenhofer P.A. represents institutional investors and shareholders internationally in securities class actions, corporate governance actions and derivative litigation. The firm has recovered more than $13 billion for shareholders in the last five years and has consistently been cited by RiskMetrics for securing among the highest average investor recovery in securities class actions. Grant & Eisenhofer has been named one of the country's top plaintiffs' law firms by The National Law Journal for the past six years. For more about Grant & Eisenhofer, visit or

From: Allan Ripp 212-262-7477
James Bourne 212-262-7470

SOURCE Grant & Eisenhofer P.A.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. U.S. FDA Grants Priority Review to the New Drug Application for Bayers Regorafenib to Treat Patients with Metastatic Colorectal Cancer
2. Spot On Sciences Awarded $1 Million DARPA Grant to Develop a Blood Sample Collection Device
3. Sirnaomics Received NIH SBIR Grant for Developing Its Scarless Wound Healing siRNA Therapeutics
4. ReShape Medical Appoints Robert E. Grant to Board of Directors
5. Community Foundation Announces $2.6 Million In Grants From Centinela Medical Funds
6. Sorrento Therapeutics Awarded Third Phase I STTR Grant
7. Nektar Announces that FDA Grants Fast Track Designation to NKTR-181, a New Oral Opioid Analgesic Molecule, for the Treatment of Moderate to Severe Chronic Pain
8. Brain Research Foundation Announces Grant To Study Concussive Events Among Grade School Children
9. Oramed Pharmaceuticals Granted Core Technology Patent in New Zealand
10. QRxPharma Granted Additional US Patent on MoxDuo®
11. Health Diagnostic Laboratory, Inc. Provides Grant to Support National Lipid Association, Sponsors 2012 Annual Scientific Sessions in Scottsdale, Arizona
Post Your Comments:
(Date:12/1/2015)... , Dec. 1, 2015 ... today announced that its Chief Executive Officer, ... the Oppenheimer Annual Healthcare Conference in New ... in the conference through a webcast on ... , --> ...
(Date:12/1/2015)... Pharma Tech Outlook recently conducted a comprehensive ... Management Solution Providers - 2015 .  After careful consideration ... CIOs, VCs, analysts, and the Pharma Tech Outlook editorial ... 10 clinical data management solution providers (check out the ... 36 respectively). --> ...
(Date:12/1/2015)... , 1 de diciembre de 2015 /PRNewswire/ ... para cuchillas de precisión, develó hoy un ... identidad de marca. El nuevo logo destaca ... y la ingeniería de productos con cuchillas ... ...
Breaking Medicine Technology:
(Date:12/1/2015)... ... December 01, 2015 , ... World Patent Marketing , ... a container patent that allows for easier packing and organizing of items into one ... $90 billion," says Scott Cooper, CEO and Creative Director of World Patent Marketing and ...
(Date:12/1/2015)... ... December 01, 2015 , ... Integrated Rental Services ... Jordan Industries International, LLC (“JII”). , With support from JII, Integrated Rental is ... to hospitals, surgery centers, clinics, research labs and medical facilities across the United ...
(Date:12/1/2015)... Fla. (PRWEB) , ... December 01, 2015 , ... ... number of leadless pacemakers in the U.S. and is the only hospital in ... from the largest clinical data presentation of transcatheter pacing patients were revealed recently ...
(Date:12/1/2015)... ... December 01, 2015 , ... Growth in medical payments per workers’ compensation ... utilization of hospital and nonhospital care, according to a recent study by the Workers ... 16th Edition , found medical payments per claim with more than seven days of ...
(Date:12/1/2015)... ... ... It’s official: Tattoo taboo is a thing of the past. One in five ... one in three aged 18 to 25 is inked). As tattoos transition to mainstream ... fact, RealSelf , the world’s largest community for learning and sharing information about ...
Breaking Medicine News(10 mins):